Market revenue in 2022 | USD 7,241.1 million |
Market revenue in 2030 | USD 16,916.9 million |
Growth rate | 11.2% (CAGR from 2022 to 2030) |
Largest segment | Artificial organ |
Fastest growing segment | Artificial bionics |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Artificial Organ, Artificial bionics |
Key market players worldwide | Zimmer Biomet Holdings Inc, Boston Scientific Corp, Cochlear Ltd, Edwards Lifesciences Corp, Ekso Bionics Holdings Inc, Medtronic PLC, Symbotic Inc Ordinary Shares - Class A, Johnson & Johnson, Berlin Heart GmbH, SynCardia Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial organs and bionics market will help companies and investors design strategic landscapes.
Artificial organ was the largest segment with a revenue share of 70.54% in 2022. Horizon Databook has segmented the Asia Pacific artificial organs and bionics market based on artificial organ, artificial bionics covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific region consists of several emerging economies, such as Japan, China, and India. These countries have large populations with a high incidence of chronic diseases. An increase in the number of chronic diseases that lead to organ failure is expected to boost the demand for transplants in this region over the coming years.
The countries are advancing technologically and offer various advanced surgical procedures, with booming medical tourism. The low cost of surgical procedures in the region allows a large number of foreign patients to visit for medical reasons.
Thus, an increase in the number of chronic diseases leading to organ failure and a rise in medical tourism have contributed significantly to the growth of the organ and bionics market in the region. Asia Pacific’s market is expected to exhibit the highest CAGR of 11.5% during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific artificial organs and bionics market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific artificial organs and bionics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account